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II. Introduction
Pain management in the veterinary patient can be complicated and frustrating for both practitioners and owners. With patients that do not speak and hide their pain as an evolutionary trait it is difficult to determine the effective analgesic dose in any individual. Finding a medication that is easy to use, effective and safe can be challenging; especially when medicating dogs in the home environment. Failure to control postoperative pain can result in the development of chronic pain and complex pain syndromes which often manifest as behavioral changes. Aggression, fear, and self-mutilation are not uncommon sequelae that can damage the human animal bond and have a substantial influence on patient wellbeing and client satisfaction. Compared with other oral opioid preparations tramadol has fewer legislative requirements being classified as schedule 3 by the DEA. It is inexpensive, easy for owners to administer and has minimal effects on the kidneys or liver. (Plumb, 2005) Current dose recommendations for tramadol are wide ranging being anywhere from 2-4 mg/kg orally every 12 hours to 5-10 mg/kg orally every 6-8 hours. (Plumb, 2005 ; KuKanich, 2011) Therefore choosing a clinically effective dose can be challenging and a dose range based on both plasma concentration and corresponding clinical signs of analgesia has yet to be determined.
Tramadol is a racemic mixture of two enantiomers which have effects at the µ-opioid receptor, the δ-opioid receptor, and weakly at the κ-opioid receptor. Tramadol also inhibits endogenous serotonin and norepinephrine uptake. 
Anesthesia
A standardized anesthetic plan was used in all patients undergoing ovariohysterectomy in the laboratory. Premedication with acepromazine at 0.02-0.04mg/kg and Morphine at 0.6-1 mg/ kg was administered intramuscularly to allow for intravenous catheter placement using aseptic technique. After intravenous catheter placement, anesthesia was induced by administering propofol intravenously to effect (loss of palpebral reflex, loose jaw-tone) with or without ketamine at 2 mg/kg intravenously. The trachea was intubated and anesthesia was maintained with isoflurane to effect in oxygen. A balanced isotonic crystalloid solution (5-10 mL/kg/h, IV) was administered during surgery. Blood pressure was measured using a Doppler and sphygmomanometer, arterial hemoglobin saturation using pulse oximetry, heart rate via an esophageal stethoscope, and respiratory rate by direct observation, and intermittent end-tidal carbon dioxide concentration using capnometry were monitored during anesthesia. Anesthetic time was no less than 2 hours and no more than 6 hours from premedication to extubation for all dogs.
Appropriate level of recovery from general anesthesia was based on the patient's ability to swallow and right herself. Patients were then medicated with either the high or low dose (as previously described) of oral tramadol based on previous random assignment. The time of After the 12 hour evaluation, the study was completed and any dogs that had not received rescue analgesia during the study period were treated with meloxicam (0.1 mg/kg SQ) or carprofen (2.2 mg/kg SQ). Hydromorphone (0.05 mg/kg IM) was administered as needed.
Statistical analysis
Explanatory values included, high dose versus low dose, weight class, and time while outcome variables included, plasma drug concentration (tramadol and O-desmethyltramadol) and pain scale (GCMPS-SF). All data was input into a spreadsheet program then transferred to a statistical software package. c, d
The Shapiro-Wilks test was used to evaluate goodness of fit. All outcome variable data was entered as a mean. Bivariate analysis was used to compare outcome variables (pain score, drug plasma level) to the explanatory variable data (weight, dose). Student's t-test was used to evaluate difference in pain score between doses and weight classes, and the difference in plasma concentration of tramadol and O-desmethytramadol between weight classes and doses.
Significance was set at P<0.05
III. Results
14 intact female dogs were enrolled in the study, one dog from the greater than 15 kg group was excluded from further evaluation after a dysphoric recovery. The patient was assumed to be painful and immediate analgesia and sedation was administered without formal pain scoring. Thirteen dogs received tramadol postoperatively and were pain scored. Data for these 13 dogs was analyzed.
Pain Scoring
There was a significant difference in average pain score between the high dose and low dose groups at 6 and 8 hours when weight classes were pooled. (Figure 1 Limitations to this study include the small sample size and potentially marked differences in individual students' surgical technique and tissue handling. It is expected that seasoned veterinary practitioners would have both better surgical skills and much shorter procedure duration. A non-treatment control group was not included in this study due to ethics. Finally, while the dose administered to each dog was within 0.88 mg of the calculated dose, this variation may have led to some variability in plasma concentration and clinical analgesia.
However it is important to recognize that this study has revealed clinically significant information. Thirty to fifty percent of dogs in both the high and low dose groups across weight Patients with a pain score higher than 6 were removed from the study and provided rescue analgesia. (*) represent significant difference from baseline using the Student's t-test (p<0.05). 
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